| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,016 |
3,470 |
$264K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,104 |
2,650 |
$130K |
| 87428 |
|
413 |
392 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
474 |
434 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
282 |
251 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
613 |
268 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
420 |
334 |
$3K |
| 87430 |
|
222 |
206 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
837 |
700 |
$938.50 |
| 71045 |
Radiologic examination, chest; single view |
88 |
78 |
$876.89 |
| 71046 |
Radiologic examination, chest; 2 views |
31 |
31 |
$528.39 |
| 81002 |
|
260 |
227 |
$490.40 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
19 |
16 |
$459.20 |
| 90756 |
|
12 |
12 |
$233.90 |
| 90656 |
|
38 |
36 |
$131.43 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
15 |
12 |
$76.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
57 |
53 |
$21.11 |
| 3074F |
|
560 |
493 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
61 |
47 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
15 |
15 |
$0.00 |
| 3079F |
|
48 |
42 |
$0.00 |
| 1159F |
|
1,123 |
946 |
$0.00 |
| 3078F |
|
516 |
449 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
117 |
100 |
$0.00 |
| 3077F |
|
20 |
13 |
$0.00 |